[The effectiveness of cytoflavin in complex therapy of patients with the coronavirus infection COVID-19].

E V Yekusheva V B Vojtenkov O A Rizakhanova

Published in: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova (2022)

The use of the drug Cytoflavin in the complex therapy of patients with COVID-19 infection is pathogenetically justified and expedient. The data obtained make it possible to recommend the inclusion of Cytoflavin in the treatment protocols for patients with COVID-19 coronavirus infection to optimize therapy and improve the course and outcome of the disease, as well as a longer use of Cytoflavin and repeated courses of its use in patients with COVID-19 infection.

Keyphrases

sars cov
coronavirus disease
randomized controlled trial
systematic review
emergency department
stem cells
machine learning
bone marrow
artificial intelligence
deep learning